Contact information
Type
Scientific
Primary contact
Mr Rami Jumnoodoo
ORCID ID
Contact details
Park Royal Centre for Mental Health
Acton Lane
Central Way
London
NW10 7NS
United Kingdom
+44 (0)20 8955 4444
rami.jumnoodoo@nhs.net
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
JUMRC6002
Study information
Scientific title
Acronym
RPGP
Study hypothesis
Following an eight week Relapse Prevention (RP) programme, service users have:
1. Decrease in admission rates
2. Decrease in length of stay following admission
3. Increase in the attendance rates of hospital appointments
4. Increased their self-efficacy
5. Greater knowledge in medication, support services and illnesses
6. Improved quality of life
7. Reduced severity of symptomatology
It is expected that there will be a significant difference in these variables between individuals receiving the RP programme (treatment group) and individuals receiving treatment as usual (comparison group) that this is maintained at three and six months follow-up.
Ethics approval
COREC - Brent Medical Ethics Committee
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Not specified
Trial type
Treatment
Patient information sheet
Condition
Schizophrenia
Intervention
Relapse prevention programme as opposed to treatment as usual
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measure
1. Increased self-efficacy
2. Greater knowledge in medication, support services and illnesses
3. Improved quality of life
4. Reduced severity of symptomatology
Secondary outcome measures
1. Decrease in admission rates
2. Decrease in length of stay following admission
3. Increase in the attendance rates of hospital appointments
Overall trial start date
11/09/2006
Overall trial end date
11/05/2007
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
1. Newly diagnosed by a Community Psychiatric Nurse (CPN)
2. Age group 18-45, men and women
3. Have a diagnosis of schizophrenia (ICD 10-F20)
4. Sufficiently stable to take part in the programme
5. Assessment conducted by CPN
6. Living in the community
7. Be able to consent to participate
8. Be on a therapeutic dose of anti-psychotic medication
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
96
Participant exclusion criteria
1. Patients who do not speak English or cannot use an interpreter because this will be another confounder to the study
2. Patients with drug dependency as indicated by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)although alcohol/drug abusers will still be eligible for the study. The DSM- IV criterion for abuse is very restrictive and would capture most alcohol/drug use by mental health service users. The CPNs will be provided with this to make this assessment
3. Organic brain diseases (e.g. dementia) as assessed by the psychiatrist. The psychiatrist will be asked to assess whether the patient is capable of giving informed consent and understanding what they have been asked to do
4. Patients who have previously been treated with RP
5. Patients who refuse to provide consent
Recruitment start date
11/09/2006
Recruitment end date
11/05/2007
Locations
Countries of recruitment
United Kingdom
Trial participating centre
Park Royal Centre for Mental Health
London
NW10 7NS
United Kingdom
Funders
Funder type
Hospital/treatment centre
Funder name
Funded by Brent Mental Health Service and The Brent Relapse Prevention Programme (UK)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Publication list
2008 results in http://www.ncbi.nlm.nih.gov/pubmed/18768007
Publication citations
-
Results
Foster JH, Jumnoodoo R, Relapse prevention in serious and enduring mental illness: a pilot study., J Psychiatr Ment Health Nurs, 2008, 15, 7, 552-561, doi: 10.1111/j.1365-2850.2008.01265.x.